Subscribe
Date
Past
2015
2016
2017
2018
2019
2020
Upcoming

Brian Shapiro, Ph.D., is adept at developing assays that incorporate primary cells. Join this webinar to hear this ATCC expert cover the following key points:

  • Differentiated iPSCs lend the ability to run large toxicity studies and drug screens on highly biologically relevant cells.
  • ATCC iPSCs were used as the source for three types of differentiated cells: CD34+ progenitors, mesenchymal stem cells (MSCs), and monocytes.
  • ATCC R&D scientists have generated in-depth data showing the iPSC-derived cells can be incorporated into immunoassays and further differentiated into cell types such as osteocytes, chondrocytes, and adipocytes.

In this webinar, ATCC microbiologist Britany Tang will give an overview of the novel coronavirus SARS-CoV-2 that presents these key points:

  • Understanding the nature of the disease (COVID-19)
  • Understanding what other coronaviruses tell us about SARS-CoV-2 history, genomics, and epidemiology
  • Explaining the advancements in scientific and clinical research and development and how ATCC is contributing to the fight against COVID-19

In this webinar Diversigen, Inc. scientist Dr. Tasha Santiago-Rodrigues will discuss the field of viral metagenomics, focusing on the following key points:

  • Implementation of viral standards and controls can help determine biases that could be potentially introduced at different stages of a viral metagenomics pipeline.
  • Identification of biases in a viral metagenomics study provides the opportunity to troubleshoot and benchmark reagents and analysis tools. 
  • Viral standards may evolve to mimic simple and more complex viral communities in diverse environments.